Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Open Biol ; 11(12): 210140, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34905700

RESUMEN

Bipolar disorder (BPD) is a psychiatric disorder characterized by alternate episodes of mania and depression. Disruption of normal circadian clock and abnormal sleep cycles are common symptoms of BPD patients. Lithium salt is currently an effective clinical therapeutic drug for BPD. Animal and cellular studies have found that lithium salt can upregulate the expression of the clock gene Per2, but the mechanism is unknown. We aim to understand the mechanism underlying the Per2 upregulation by lithium treatment. By taking approaches of both comparative transcriptome analysis and comparative qPCR analysis between human and murine cells, Lumicycle assay, luciferase assay and RT-qPCR assay showed that lithium could significantly upregulate the expression of Per2 in both mouse and human cells, and significantly inhibit the expression of E4bp4, which encodes a transcriptional inhibitor of Per2. After knocking out the cis-element upstream on the Per2 promoter that responds to E4BP4, the upregulation effect on Per2 by lithium disappeared. When E4bp4 gene was knocked out, the upregulation effect on Per2 by lithium salt disappeared. This study has found that lithium upregulates Per2 expression by reducing the expression of transcription factor E4BP4, but the mechanism of lithium salt downregulation of E4BP4 remains to be further studied. Our study provides a new therapeutic target and approaches for treating BPD.


Asunto(s)
Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/genética , Trastorno Bipolar/genética , Perfilación de la Expresión Génica/métodos , Litio/administración & dosificación , Proteínas Circadianas Period/genética , Animales , Trastorno Bipolar/tratamiento farmacológico , Sistemas CRISPR-Cas , Línea Celular , Cicloheximida/farmacología , Edición Génica , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Litio/farmacología , Ratones , Mutagénesis Sitio-Dirigida , Células 3T3 NIH , Regiones Promotoras Genéticas , Análisis de Secuencia de ARN , Regulación hacia Arriba
2.
Int J Mol Sci ; 21(7)2020 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-32252431

RESUMEN

Circadian rhythm is an endogenous, self-sustainable oscillation that participates in regulating organisms' physiological activities. Key to this oscillation is a negative feedback by the main clock components Periods and Cryptochromes that repress the transcriptional activity of BMAL1/CLOCK (defined in the Abbreviations) complexes. In addition, a novel repressor, CHRONO, has been identified recently, but details of CHRONO's function during repressing the circadian cycle remain unclear. Here we report that a domain of CHRONO mainly composed of α-helixes is critical to repression through the exploitation of protein-protein interactions according to luciferase reporter assays, co-immunoprecipitation, immunofluorescence, genome editing, and structural information analysis via circular dichroism spectroscopy. This repression is fulfilled by interactions between CHRONO and a region on the C-terminus of BMAL1 where Cryptochrome and CBP (defined in the Abbreviations) bind. Our resultsindicate that CHRONO and PER differentially function as BMAL1/CLOCK-dependent repressors. Besides, the N-terminus of CHRONO is important for its nuclear localization. We further develop a repression model of how PER, CRY, and CHRONO proteins associate with BMAL1, respectively.


Asunto(s)
Relojes Circadianos , Péptidos y Proteínas de Señalización del Ritmo Circadiano/genética , Dominios y Motivos de Interacción de Proteínas , Secuencia de Aminoácidos , Sistemas CRISPR-Cas , Núcleo Celular/metabolismo , Péptidos y Proteínas de Señalización del Ritmo Circadiano/química , Péptidos y Proteínas de Señalización del Ritmo Circadiano/metabolismo , Uso de Codones , Edición Génica , Regulación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Humanos , Proteínas Circadianas Period/química , Proteínas Circadianas Period/genética , Proteínas Circadianas Period/metabolismo , Unión Proteica , Conformación Proteica , Transporte de Proteínas , Proteínas Recombinantes/genética , Análisis Espectral , Relación Estructura-Actividad
3.
Phys Chem Chem Phys ; 17(20): 13340-6, 2015 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-25923033

RESUMEN

Amorphous Mg and MgNix (0.03 ≤ x ≤ 0.30) thin films capped with Pd were prepared by magnetron co-sputtering, and their hydrogen-induced optical transitions were investigated via electrochemical charging and discharging in KOH electrolyte solution. Repetitive transitions, up to dozens of times between the mirror state and transparent state, are achieved in these amorphous Mg and MgNix thin films even though some performance degeneration occurs during cycling. These deteriorations are mainly attributed to the breakdown of the film structure, which is caused by both a large change in film volume during cycling and the corrosive attack of the KOH electrolyte. In addition, calculations based on the electrochemical stripping method indicate that the hydrogen diffusion coefficient is significantly increased by amorphization; however, it is only slightly improved by the addition of Ni. Among the prepared amorphous films, MgNi0.09 film shows the largest hydrogen diffusion coefficient, namely, 2.64 × 10(-13) cm(2) s(-1). More importantly, the optical properties of the amorphous Mg and MgNix films are readily manipulated in the charging process, especially under a small charging current density, where there is a linear correlation between charging capacity and transmittance. The tunable optical properties obtained in the present study will greatly expand the application fields of Mg-based thin films.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA